Print

Brainsway (BRSYF.PK) Reports Positive Final Results of Study Using Deep TMS to Treat OCD  
9/4/2013 9:45:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

JERUSALEM, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to report the final results of a clinical trial conducted at the Sheba Medical Center at Tel Hashomer to assess the efficacy of the Company's Deep TMS device in treating obsessive-compulsive disorder ("OCD") using a specialized coil developed for this purpose.

Help employers find you! Check out all the jobs and post your resume.

//-->